Table 1.

Patient demographics

Chemotherapy naïve (N = 5)After 1 cycle of chemotherapy (N = 20)After 3 cycles of chemotherapy (N = 20)After 7 cycles of chemotherapy (N = 19)Patients with a history of previous chemotherapy (N = 12)
Age (median), y4945.5455046
Postmenopausal, n (%)3 (60)3 (15)9 (45)7 (35)6 (50)
Hormonal therapy, n (%)0 (0)0 (0)0 (0)0 (0)9 (75)
Chemotherapy regimen, n (%)
 FECN/A1 (5)4 (20)N/AN/A
 ACN/A15 (75)9 (45)N/AN/A
 DOCN/A4 (20)7 (35)N/AN/A
 FEC-DOCN/AN/AN/A15 (79)8 (67)
 AC-DOCN/AN/AN/A3 (16)0 (0)
 OtherN/AN/AN/A1 (5)4 (33)
Days from first chemotherapy (median)N/A2163154944

Abbreviations: AC, adriamycin and cyclophosphamide; DOC, docetaxel; FEC, 5-fluorouracil, epirubicin, and cyclophosphamide; N/A, not applicable.